IP Library Granted Patent US 8,852,649
Granted Patent B2
US 8,852,649 · App. 11/741,797 · Granted Oct 7, 2014

Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,852,649
App. No.
11/741,797
Granted
Oct 7, 2014
Kind
B2
Abstract

Methods for treating colon cancer include administering, to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to treat colon cancer, which composition inhibits COX-2. Methods for treating inflammation locally in the intestines comprise administering, to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to treat inflammation. In one embodiment, the polymeric proanthocyanidin compound is crofelemer.

Claims (6)

1. A method of treating colon cancer in a subject, comprising administering to a subject having colon cancer an amount of isolated crofelemer effective to treat colon cancer.

2. The method of claim 1 , in which crofelemer is administered in a range of about 50 mg per day to 2000 mg per day.

3. The method of claim 1 , wherein the crofelemer is administered orally.

4. The method of claim 1 , wherein the crofelemer is enteric protected crofelemer.

5. The method of claim 4 , wherein the enteric protected crofelemer is enteric coated tablets, beads or granules.

6. The method of claim 1 , wherein the crofelemer is formulated as a controlled release pharmaceutical composition.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: HERCULES CAPITAL, INC.
To: JAGUAR HEALTH, INC.
Reel/Frame 045496/0039 →
SECURITY INTEREST Recorded Nov 22, 2017
From: NAPO PHARMACEUTICALS, INC.
To: KINGDON CAPITAL MANAGEMENT, L.L.C.
Reel/Frame 044497/0954 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2017
From: NANTUCKET INVESTMENTS LIMITED
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 043380/0655 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 12, 2016
From: JAGUAR ANIMAL HEALTH, INC.
To: HERCULES TECHNOLGY GROWTH CAPITAL, INC., AS AGENT
Reel/Frame 037809/0161 →
SECURITY AGREEMENT Recorded Mar 7, 2012
From: NAPO PHARMACEUTICALS, INC.
To: NANTUCKET INVESTMENTS LIMITED
Reel/Frame 027830/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2007
From: QUART, BARRY D.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 019560/0973 →